Scarica l'app Stockscreener
392.15
0.48%
-1.88
Dopo l'orario di chiusura:
391.09
-1.06
-0.27%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
West Pharmaceutical Services Inc Borsa (WST) Ultime notizie
West Pharmaceutical Services Inc Unsponsored Brazilian Depositary Receipt Repr 0.0285714 Sh - TradingView
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
West Pharmaceutical Services, I (WST) Stock Forecasts - Yahoo! Finance Canada
West Pharmaceutical Services, I (WST) Stock Forecasts - Yahoo Finance
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
West Pharmaceutical Services (WST) Raises Quarterly Dividend by 18.2% - GuruFocus
West Pharmaceutical Services Raises Quarterly Dividend 18% to $0.26 a Share, Payable Nov. 18 to Holders as of Nov. 11. - marketscreener.com
West Declares Quarterly Dividend - PR Newswire
A company has raised its dividend for 34 straight years. Its next payment is $0.26 per share. - Stock Titan
Press Release: West Declares Quarterly Dividend - Moomoo
3 Low-Volatility Stocks We’re Skeptical Of - FinancialContent
West Pharmaceutical Sets October 29 Earnings Release - MyChesCo
West Pharmaceutical Services (NYSE:WST): What Does the S&P 500 Context Reveal? - Kalkine Media
West Pharmaceutical Services stock hits 52-week high at $386.08 By Investing.com - Investing.com South Africa
West Pharmaceutical Services stock hits 52-week high at $386.08 - Investing.com
West Pharmaceutical Services stock hits 52-week high at $386.08 By Investing.com - Investing.com Nigeria
West Pharmaceutical Services Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
West Pharmaceutical Services Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
What Do West Pharmaceutical Services' Latest Results Reveal About This S&P 500 Stock (NYSE:WST)? - Kalkine Media
West Pharmaceutical Stock Gains 36.1% YTD: What's Behind the Rally? - TradingView
West Pharmaceutical Stock Gains 36.1% YTD: What's Behind the Rally? - Yahoo Finance
Meta, JPMorgan, West Pharmaceutical And More: CNBC’s ‘Final Trades’ - Benzinga
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
Here's Why You Should Retain DexCom Stock in Your Portfolio for Now - Zacks Investment Research
Veeva Systems' Basics Gains Traction With 175+ Emerging Biotech Firms - Zacks Investment Research
TD Cowen Adjusts Price Target on West Pharmaceutical Services to $420 From $410 - Yahoo Finance
ANGO Q1 Earnings Beat Estimates on Med Tech Growth, Revenues Up Y/Y - Zacks Investment Research
Reasons to Hold Veeva Systems Stock in Your Portfolio for Now - Zacks Investment Research
Smith+Nephew Launches CARTIHEAL Implant Across Key European Markets - Zacks Investment Research
Here's Why You Should Retain WAT Stock in Your Portfolio for Now - Zacks Investment Research
Third-quarter results are due before markets open Oct. 29; West Pharmaceutical's call follows at 8 a.m. - Stock Titan
West Pharmaceutical Services Needs Faster Earnings Growth To Justify Its Price (NYSE:WST) - Seeking Alpha
West Pharmaceutical Services (WST) Stock Could Be 17% Overvalued As Cash Flow Falls Short - Yahoo Finance
West Pharmaceutical Services Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Reasons to Retain Fresenius Medical Stock in Your Portfolio for Now - Zacks Investment Research
BDX Expands U.S. Manufacturing With $19B Healthcare Investment - Zacks Investment Research
Reasons to Hold HealthEquity Stock in Your Portfolio for Now - Zacks Investment Research
Veeva's DQS Scales Data Automation Across 1,000+ Clinical Studies - Zacks Investment Research
West Pharmaceutical: Still A Buy, But Expectations Are Rising - Seeking Alpha
PCR Packaging For Pharma And Otc Market 7.2% CAGR to 2035 on ESG MandatesNews and Statistics - IndexBox
GE HealthCare Expands U.S. PET Radiopharma Reach With SOFIE Deal - TradingView
Reasons to Retain Cardinal Health Stock in Your Portfolio for Now - Zacks Investment Research
Reasons to Retain Cardinal Health Stock in Your Portfolio for Now - TradingView
Barclays Raises West Pharmaceutical Services Price Target to $440 From $400, Maintains Overweight Rating - marketscreener.com
West Pharmaceutical Services Highlights Leadership & Expertise - Contract Pharma
Is West Pharmaceutical Services Inc (WST) Overvalued After 3.2% - GuruFocus
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
Reasons to Retain Doximity Stock in Your Portfolio for Now - Zacks Investment Research
What to Expect From West Pharmaceutical Services' Next Quarterly Earnings Report - Yahoo Finance
What to Expect From West Pharmaceutical Services' Next Quarterly Earnings Report - inkl
2.26%
0.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):